$ZBIO SEC Filings

Filed On	Filing
13 Oct 2026	8-K: Regulation FD Disclosure Zenas BioPharma Announces the Presentation of New Obexelimab Data in IgG4-Related Disease at the 6th International Symposium on IgG4-Related Disease
11 Sep 2026	S-3ASR
11 Sep 2026	FORM S-8
08 Sep 2026	SCHEDULE 13G
08 Sep 2026	Form 3: InnoCare Pharma Inc., 10% owner Holds 7,000,000 shares of Common Stock
08 Sep 2026	SCHEDULE 13G/A
02 Sep 2026	Form 4: Oliger Christy J., Director Granted 37,000 Stock Option (Right to Buy)
02 Sep 2026	Form 3: Oliger Christy J., Director No securities owned
19 Aug 2026	SCHEDULE 13D/A
19 Aug 2026	144
17 Aug 2026	SCHEDULE 13D/A
13 Aug 2026	10-Q
13 Aug 2026	8-K: Results of Operations and Financial Condition; Departure/Election of Directors or Officers; Compensation
17 Jun 2026	Form 4: Nunn Jason Raleigh, Director Granted 18,500 Stock Option (Right to Buy)
17 Jun 2026	Form 4: Lu Hongbo, Director Granted 18,500 Stock Option (Right to Buy)
17 Jun 2026	Form 4: Moulder Leon O Jr, Director Granted 500,000 Stock Option (Right to Buy)
17 Jun 2026	Form 4: Orloff John J, Director Granted 18,500 Stock Option (Right to Buy)
17 Jun 2026	Form 4: von Moltke Lisa, See Remarks Granted 150,000 Stock Option (Right to Buy)
17 Jun 2026	Form 4: Allen Patricia L, Director Granted 18,500 Stock Option (Right to Buy)
17 Jun 2026	Form 4: Boylan James P, Director Granted 18,500 Stock Option (Right to Buy)

Comments